Unknown

Dataset Information

Genomic Fingerprint Associated with Familial Idiopathic Pulmonary Fibrosis: A Review.


ABSTRACT: Idiopathic pulmonary fibrosis (IPF) is a severe interstitial lung disease; although the recent introduction of two anti-fibrosis drugs, pirfenidone and Nidanib, have resulted in a significant reduction in lung function decline, IPF is still not curable. Approximately 2-20% of patients with IPF have a family history of the disease, which is considered the strongest risk factor for idiopathic interstitial pneumonia. However, the genetic predispositions of familial IPF (f-IPF), a particular type of IPF, remain largely unknown. Genetics affect the susceptibility and progression of f-IPF. Genomic markers are increasingly being recognized for their contribution to disease prognosis and drug therapy outcomes. Existing data suggest that genomics may help identify individuals at risk for f-IPF, acc

SUBMITTER: Ding D 

PROVIDER: S-EPMC9969503 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature